ID   HEC-88nu
AC   CVCL_2932
SY   HEC-88 nu; HEC88nu; HEC88NU; HEC-88
DR   BioSample; SAMN03470941
DR   Cosmic; 1223493
DR   Cosmic; 1696751
DR   IARC_TP53; 21069
DR   JCRB; JCRB1121
DR   JCRB; NIHS0393
DR   Wikidata; Q54882269
RX   DOI=10.1007/978-4-431-53981-0_1;
RX   DOI=10.5795/jjscc.26.433;
RX   PubMed=2064198;
RX   PubMed=12227503;
RX   PubMed=15053063;
RX   PubMed=25877200;
RX   PubMed=28196595;
WW   https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Characteristics: Established from a tumor transplanted in nude mice.
CC   Doubling time: 43.8 hours (Note=At 58th passage) (DOI=10.5795/jjscc.26.433); 48 hours (PubMed=2064198).
CC   Omics: Protein expression by reverse-phase protein arrays.
CC   Discontinued: JCRB; NIHS0393; true.
ST   Source(s): JCRB=JCRB1121; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,13
ST   D16S539: 11
ST   D18S51: 14,16,17
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 5,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
RX   DOI=10.1007/978-4-431-53981-0_1;
RA   Kuramoto H., Hamano M., Imai M., Fujisawa T., Kamata Y., Arai T.,
RA   Kawaguchi M.;
RT   "HEC-1 cells: establishment of an in vitro experimental system in
RT   endometrial carcinoma.";
RL   (In book chapter) Cell and molecular biology of endometrial carcinoma; Kuramoto H., Nishida M. (eds.); pp.3-34; Springer; Tokyo; Japan (2003).
//
RX   DOI=10.5795/jjscc.26.433;
RA   Morisawa T.;
RT   "The results of primary culture of endometrial adenocarcinoma and
RT   characterization of its established cell line.";
RL   Nihon Rinsho Saibo Gakkai Zasshi 26:433-442(1987).
//
RX   PubMed=2064198; DOI=10.1111/j.1749-6632.1991.tb37884.x;
RA   Kuramoto H., Nishida M., Morisawa T., Hamano M., Hata H., Kato Y.,
RA   Ohno E., Iida T.;
RT   "Establishment and characterization of human endometrial cancer cell
RT   lines.";
RL   Ann. N. Y. Acad. Sci. 622:402-421(1991).
//
RX   PubMed=12227503; DOI=10.1111/j.1749-0774.2002.tb00103.x;
RA   Kuramoto H., Hamano M., Imai M.;
RT   "HEC-1 cells.";
RL   Hum. Cell 15:81-95(2002).
//
RX   PubMed=15053063;
RA   Kamata Y., Watanabe J., Hata H., Hamano M., Kuramoto H.;
RT   "Quantitative study on the correlation between p53 gene mutation and
RT   its expression in endometrial carcinoma cell lines.";
RL   Eur. J. Gynaecol. Oncol. 25:55-60(2004).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076;
RA   Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P.,
RA   Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L.,
RA   Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D.,
RA   Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B.,
RA   Liang H.;
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//